Table 1.
Laboratory test (reference range) | Day 4 | Day 7 | Day 8 | Day 9 | Day 10 | Day 13 |
---|---|---|---|---|---|---|
Hemoglobin, g/dL (11.5–15.3) | 14.4 | 16.4 | 13.2 | 12.3 | 13.1 | 12.7 |
Leukocyte, ×103/μL (4–9.5) | 3.0 | 4.9 | 3.9 | 4.2 | 4.2 | 4.4 |
Neutrophil, % (39–73) | NA | 45 | 32 | 61 | 56 | 59 |
Lymphocyte, % (19–50) | NA | 36 | 52 | 29 | 35 | 27 |
Atypical lymphocyte, % (0) | NA | 15 | 3 | 0 | 0 | 0 |
Erythroblast, cell/100 WBC (0) | NA | 1 | 0 | 0 | 0 | 0 |
Platelet, ×103/μL (150–400) | 61 | 73 | 79 | 89 | 241 | 431 |
AST, IU/L (11–35) | 157 | 267 | 192 | 147 | 86 | 42 |
ALT, IU/L (5–35) | 66 | 122 | 97 | 89 | 82 | 56 |
Creatine kinase, IU/L (45–235) | 155 | 207 | 127 | 86 | 52 | 31 |
LDH, IU/L (120–230) | 483 | 577 | 437 | 356 | 284 | 206 |
aPTT, sec (20–35) | NA | 33.8 | 31.3 | 30.5 | 29.3 | 26.9 |
Prothrombin time, INR (0.8–1.2) | NA | 0.88 | 0.89 | 0.92 | 0.98 | 1.03 |
C-reactive protein, mg/dL (0–0.5) | 1.10 | 0.23 | 0.15 | 0.26 | 0.29 | 0.04 |
*Day 1 was onset day. NA: not available; WBC: white blood cell; AST: aspartate aminotransferase; ALT: alanine aminotransferase; LDH: lactate dehydrogenase; aPTT: activated partial prothromboplastin time; INR: international normalized ratio.